| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Pathology,*
Internal
Medicine,
and
Surgery,
Section of Urology, University of
Michigan, Ann Arbor, Michigan
Postatrophic hyperplasia (PAH) of the prostate gland often demonstrates overlapping histological features with prostatic adenocarcinoma (PCA). These features include small acinar growth and enlarged nuclei with prominent nucleoli. Recent work has demonstrated that PAH is a proliferative, noninvoluting lesion. PAH is also histologically distinct from simple atrophy (SA), which has intermediate- to large-sized glands, minimal cytoplasm, and inconspicuous nuclei. However, despite overlapping features between PAH and PCA, high-grade prostatic intraepithelial neoplasm (HGPIN) is still considered the only direct neoplastic precursor to PCA. HGPIN resembles PCA in its topographic distribution, cytological appearance, and molecular alterations including chromosome 8p loss and chromosome 8 centromeric gain. To examine the hypothesis that PAH is the earliest histologically distinct precursor to HGPIN or PCA, the frequency, distribution, proliferative state, and chromosome 8 gain of benign prostate, SA, PAH, HGPIN, and PCA were analyzed. Forty radical prostatectomy specimens from men with clinically localized PCA were systematically analyzed. Proliferation was determined by Ki-67 immunohistochemistry (MIB-1) on formalin-fixed, paraffin-embedded tissue and quantified by digital image analysis from a total of 5,510 sample areas with benign, SA, PAH, HGPIN, and PCA. A tissue microarray was constructed to evaluate 8c gain using interphase fluorescence in situ hybridization. SA foci (n = 129) and PAH foci (n = 114) were identified in the 40 cases of which 74% (95 of 129) and 88% (100 of 114) were seen in the peripheral zone, respectively (P = 0.006). PAH and SA were identified adjacent to PCA in 28% (32 of 114) and 14% (18 of 129) of foci examined, respectively (P = 0.007). The median number of proliferating nuclei increased significantly from benign (1.20%), SA (2.67%), PAH (3.62%), HGPIN (6.14%), to PCA (12.00%) (P < 0.001). The median percentage of nuclei with more than three centromeric probe signals (chromosome 8c gain) for SA, HGPIN, PAH, and PCA were 2.1, 2.8, 4.0, and 6.0%, respectively, as compared to benign prostate with 1.3% (P = 0.006). In conclusion, the present study identified a strong topographic association between PAH and PCA. PAH is also seen often to be closely associated with chronic inflammation. Proliferation of PAH is significantly greater than benign prostatic epithelium and SA but less than HGPIN or PCA. Gain of 8c is significantly greater in PAH than benign prostate, SA, and even HGPIN. These findings demonstrate a strong association between PAH and PCA, supporting its role as a neoplastic precursor.
This article has been cited by other articles:
 |
|
 |
|
  D. Das, K. Wojno, and M. J. Imperiale BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages J. Virol., March 15, 2008; 82(6): 2705 - 2714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ulamec, D. Tomas, C. Ensinger, H. Cupic, M. Belicza, G. Mikuz, and B. Kruslin Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocarcinoma J. Clin. Pathol., October 1, 2007; 60(10): 1098 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Kim, S. M. Dhanasekaran, R. Mehra, S. A. Tomlins, W. Gu, J. Yu, C. Kumar-Sinha, X. Cao, A. Dash, L. Wang, et al. Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression Cancer Res., September 1, 2007; 67(17): 8229 - 8239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Bethel, D. Faith, X. Li, B. Guan, J. L. Hicks, F. Lan, R. B. Jenkins, C. J. Bieberich, and A. M. De Marzo Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion. Cancer Res., November 15, 2006; 66(22): 10683 - 10690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Schottenfeld and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin, March 1, 2006; 56(2): 69 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, J. Lowey, F. Wiklund, J. Sun, F. Lindmark, F.-C. Hsu, L. Dimitrov, B. Chang, A. R. Turner, W. Liu, et al. The Interaction of Four Genes in the Inflammation Pathway Significantly Predicts Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2563 - 2568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Hughes, A Murphy, C Martin, O Sheils, and J O'Leary Molecular pathology of prostate cancer J. Clin. Pathol., July 1, 2005; 58(7): 673 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Palapattu, S. Sutcliffe, P. J. Bastian, E. A. Platz, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson Prostate carcinogenesis and inflammation: emerging insights Carcinogenesis, July 1, 2005; 26(7): 1170 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sun, F. Wiklund, S. L. Zheng, B. Chang, K. Balter, L. Li, J.-E. Johansson, G. Li, H.-O. Adami, W. Liu, et al. Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk J Natl Cancer Inst, April 6, 2005; 97(7): 525 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Zheng, K. Augustsson-Balter, B. Chang, M. Hedelin, L. Li, H.-O. Adami, J. Bensen, G. Li, J.-E. Johnasson, A. R. Turner, et al. Sequence Variants of Toll-Like Receptor 4 Are Associated with Prostate Cancer Risk: Results from the CAncer Prostate in Sweden Study Cancer Res., April 15, 2004; 64(8): 2918 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Shappell, G. V. Thomas, R. L. Roberts, R. Herbert, M. M. Ittmann, M. A. Rubin, P. A. Humphrey, J. P. Sundberg, N. Rozengurt, R. Barrios, et al. Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee Cancer Res., March 15, 2004; 64(6): 2270 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Inflammation, Dietary Carcinogens, Glutathione S-Transferase {pi}, and Prostatic Carcinogenesis: WILLIAM G. NELSON, ANGELO M. DE MARZO, THEODORE L. DEWEESE, AND WILLIAM B. ISAACS, The Departments of Oncology, Urology, Pathology, Pharmacology, and Medicine, The Johns Hopkins University School of Medicine, and The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland Toxicol Pathol, January 1, 2004; 32(1): 143 - 144. [PDF]
|
|
|
|
 |
|
 M. Nakayama, C. J. Bennett, J. L. Hicks, J. I. Epstein, E. A. Platz, W. G. Nelson, and A. M. De Marzo Hypermethylation of the Human Glutathione S-Transferase-{pi} Gene (GSTP1) CpG Island Is Present in a Subset of Proliferative Inflammatory Atrophy Lesions but Not in Normal or Hyperplastic Epithelium of the Prostate: A Detailed Study Using Laser-Capture Microdissection Am. J. Pathol., September 1, 2003; 163(3): 923 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Prostate Cancer N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Iczkowski and C. G. Pantazis Overexpression of NSAID-Activated Gene Product in Prostate Cancer International Journal of Surgical Pathology, July 1, 2003; 11(3): 159 - 166. [Abstract] [PDF]
|
|
|
|
|
|
G. J. L. H. van Leenders, W. R. Gage, J. L. Hicks, B. van Balken, T. W. Aalders, J. A. Schalken, and A. M. De Marzo Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy Am. J. Pathol., May 1, 2003; 162(5): 1529 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ernst, M. Hergenhahn, M. Kenzelmann, C. D. Cohen, M. Bonrouhi, A. Weninger, R. Klaren, E. F. Grone, M. Wiesel, C. Gudemann, et al. Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma : A Gene Expression Analysis on Total and Microdissected Prostate Tissue Am. J. Pathol., June 1, 2002; 160(6): 2169 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Rubin, M. Zhou, S. M. Dhanasekaran, S. Varambally, T. R. Barrette, M. G. Sanda, K. J. Pienta, D. Ghosh, and A. M. Chinnaiyan {alpha}-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer JAMA, April 3, 2002; 287(13): 1662 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zha, W. R. Gage, J. Sauvageot, E. A. Saria, M. J. Putzi, C. M. Ewing, D. A. Faith, W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Cyclooxygenase-2 Is Up-Regulated in Proliferative Inflammatory Atrophy of the Prostate, but not in Prostate Carcinoma Cancer Res., December 1, 2001; 61(24): 8617 - 8623. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
